SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-22-013526
Filing Date
2022-07-29
Accepted
2022-07-29 17:27:14
Documents
16
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-K/A acst-20220331.htm   iXBRL 10-K/A 949959
2 EX-31.3 acst-ex31_3.htm EX-31.3 17171
3 EX-31.4 acst-ex31_4.htm EX-31.4 17375
4 EX-32.3 acst-ex32_3.htm EX-32.3 16586
5 EX-32.4 acst-ex32_4.htm EX-32.4 18135
  Complete submission text file 0000950170-22-013526.txt   1283342

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acst-20220331.xsd EX-101.SCH 2680
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acst-20220331_lab.xml EX-101.LAB 29120
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acst-20220331_pre.xml EX-101.PRE 18010
10 EXTRACTED XBRL INSTANCE DOCUMENT acst-20220331_htm.xml XML 10047
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-35776 | Film No.: 221122013
SIC: 2834 Pharmaceutical Preparations